True North Advisors, LLC Equillium, Inc. Transaction History

True North Advisors, LLC

  • $378 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$0.83 - $2.26 $73,919 - $201,275
89,060 Added 50.51%
265,370 $281,000
Q3 2022

Nov 10, 2022
SELL
$1.93 - $3.14 $274 - $445
-142 Reduced 0.08%
176,310 $176,000
Q2 2022

Jul 28, 2022
SELL
$1.69 - $3.26 $405 - $782
-240 Reduced 0.14%
176,452 $176,000
Q1 2022

May 12, 2022
BUY
$2.99 - $4.19 $528,309 - $740,339
176,692 New
176,692 $176,000

Others Institutions Holding EQ

# of Institutions
27
Shares Held
11.5M
Call Options Held
38.1K
Put Options Held
0
View Full List

About Equillium, Inc.

EQ Quotes by TradingView
  • Ticker EQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,352,100
  • Market Cap $47.1M
  • Description
  • Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...
More about EQ
Track This Portfolio

Track True North Advisors, LLC Portfolio

Follow True North Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of True North Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on True North Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email